• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

DWSBIOO:GR

161.31 EUR 0.000.00%

As of 01:59:30 ET on 10/24/2014.

Snapshot for DWS Biotech (DWSBIOO)

Year To Date: +37.99% 3-Month: +18.09% 3-Year: +45.27% 52-Week Range: 105.93 - 161.31
1-Month: +6.78% 1-Year: +45.58% 5-Year: +31.45% Beta vs NBI: 0.95

Mutual Fund Chart for DWSBIOO

No chart data available.
  • DWSBIOO:GR 161.31
  • 1M
  • 1Y
Interactive DWSBIOO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for DWSBIOO

DWS Biotech is an open-end fund incorporated in Germany. The Fund's objective is capital growth. The Fund invests primarily in biotech equities worldwide. The Fund focuses on companies in the U.S. and the portfolio may also include selected pharmaceutical and medical equipment firms. The Fund's investment is oriented on the MSCI BioTecnology Select Index.

Inception Date: 08-16-1999 Telephone: Tel. 49-1803-10111011
Managers: NOUSHIN IRANI TURNER / HOLGER GEISSLER
Web Site: www.dws.de

Fundamentals for DWSBIOO

NAV (on 2014-10-24) 161.31
Assets (M) (on 2014-10-24) 325.37
Fund Leveraged N
Minimum Investment 0.00
Minimum Subsequent Investment -

Dividends for DWSBIOO

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2014-10-01) 0.02
Dividend Yield (ttm) 0.02

Fees & Expenses for DWSBIOO

Front Load 5.00
Back Load 0.00
Current Mgmt Fee 1.50
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.70

Top Fund Holdings for DWSBIOO

Filing Date: 07/31/2014
Name Position Value % of Total
Celgene Corp 445,000 29,349,933 9.746%
Gilead Sciences Inc 390,000 27,309,318 9.069%
Biogen Idec Inc 102,317 26,317,943 8.739%
Alexion Pharmaceuticals Inc 138,600 16,937,471 5.624%
Vertex Pharmaceuticals Inc 223,050 15,322,406 5.088%
Illumina Inc 105,000 12,938,032 4.296%
Amgen Inc 125,000 12,133,231 4.029%
Regeneron Pharmaceuticals Inc 47,000 11,305,405 3.754%
BioMarin Pharmaceutical Inc 230,000 10,490,294 3.484%
Salix Pharmaceuticals Ltd 80,000 8,078,841 2.683%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil